Peptides and combination of peptides for use in immunotherapy against various tumors
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
1. A fusion protein comprising a peptide consisting of the amino acid sequence of LLWGHPRVALA (SEQ ID NO: 25) and N-terminal amino acids of the HLA-DR antigen-associated invariant chain (Ii).
2. An artificial antigen presenting cell (aAPC) comprising an MHC complex of peptide consisting of the amino acid sequence of LLWGHPRVALA (SEQ ID NO: 25) on the surface of the aAPC.
3. An aAPC comprising an MHC complex of a peptide consisiting of the amino acid sequence of LLWGHPRVALA (SEQ ID NO:25) and an anti-CD28 antibody on the surface of the aAPC.
4. The aAPC of claim 3 , wherein the MHC complex is coupled to a microbead.
5. The aAPC of claim 4 , wherein the MHC complex is coupled to the microbead by biotin-streptavidin biochemistry.
6. The aAPC of claim 4 , wherein the microbead is a polystyrene particle.
7. The aAPC of claim 3 , wherein the MHC complex and the anti-CD28 antibody are coupled to a microbead.
8. The aAPC of claim 7 , wherein the MHC complex and the anti-CD28 antibody are coupled to the microbead by biotin-streptavidin biochemistry.